Acasă › Leucemie mieloasă acută › South Carolina

Studii clinice pentru Leucemie mieloasă acută în South Carolina

16 studii pentru Leucemie mieloasă acută caută participanți în South Carolina.

Orașe în South Carolina

Text oficial al studiului (în engleză)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Prisma Health Cancer Institute - Spartanburg, Boiling Springs
Medical University of South Carolina, Charleston
Prisma Health Cancer Institute - Easley, Easley
și încă 5

În curs de recrutareFaza 2

Vârste de 18 ani și peste · Toate sexele · Actualizat 5 oct. 2026 · NCT05564390

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

AnMed Health Cancer Center, Anderson
Prisma Health Richland Hospital, Columbia
McLeod Regional Medical Center, Florence
și încă 12

În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți

Vârste de la 40 la 75 · Toate sexele · Actualizat 2 oct. 2026 · NCT05334069

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Prisma Health Cancer Institute - Spartanburg, Boiling Springs
Prisma Health Cancer Institute - Easley, Easley
Prisma Health Cancer Institute - Butternut, Greenville
și încă 4

În curs de recrutareFaza 2

Vârste de la 18 la 59 · Toate sexele · Actualizat 28 sept. 2026 · NCT05554393

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Prisma Health Cancer Institute - Spartanburg, Boiling Springs
Prisma Health Cancer Institute - Easley, Easley
Prisma Health Cancer Institute - Butternut, Greenville
și încă 4

În curs de recrutareFaza 2

Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Prisma Health Cancer Institute - Spartanburg, Boiling Springs
Medical University of South Carolina, Charleston
Prisma Health Cancer Institute - Easley, Easley
și încă 5

În curs de recrutareFaza 2

Vârste de la 18 la 59 · Toate sexele · Actualizat 22 sept. 2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Prisma Health Cancer Institute - Spartanburg, Boiling Springs
Medical University of South Carolina, Charleston
Prisma Health Cancer Institute - Easley, Easley
și încă 5

În curs de recrutareFaza 2

Vârste de 18 ani și peste · Toate sexele · Actualizat 22 sept. 2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Medical University of South Carolina, Charleston
Prisma Health Richland Hospital, Columbia
BI-LO Charities Children's Cancer Center, Greenville

În curs de recrutareFaza 3

6 Months – 21 Years · Toate sexele · Actualizat 17 sept. 2026 · NCT04293562

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

MUSC Health University Medical Center, Charleston

În curs de recrutareFaza 2

Vârste de 18 ani și peste · Toate sexele · Actualizat 15 sept. 2026 · NCT04996875

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Bon Secours St. Francis Cancer Center, Greenville

În curs de recrutareFaza 1/2

Vârste de 12 ani și peste · Toate sexele · Actualizat 3 sept. 2026 · NCT04588922

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Medical University of South Carolina, Charleston
Prisma Health Richland Hospital, Columbia
BI-LO Charities Children's Cancer Center, Greenville

În curs de recrutareFaza 1/2

Până la vârsta de 22 · Toate sexele · Actualizat 25 aug. 2026 · NCT04726241

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Prisma Health Richland Hospital, Columbia

În curs de recrutareFaza 3

29 Days – 21 Years · Toate sexele · Actualizat 24 aug. 2026 · NCT05183035

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Prisma Health, Greenville

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 20 aug. 2026 · NCT06001788

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Medical University of South Carolina, Charleston

În curs de recrutareStudiu observațional

Toate vârstele · Toate sexele · Actualizat 6 iul. 2026 · NCT01351545

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

Medical University of South Carolina, Charleston

În curs de recrutareFaza 1

Vârste de 18 ani și peste · Toate sexele · Actualizat 15 iun. 2026 · NCT02074839

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Hollings Cancer Center, Charleston

În curs de recrutareFaza 2/3

Vârste de 18 ani și peste · Toate sexele · Actualizat 30 apr. 2026 · NCT04256317

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

Medical University of South Carolina, Charleston

În curs de recrutareFaza 1/2

Vârste de 12 ani și peste · Toate sexele · Actualizat 24 mar. 2026 · NCT04988555

Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.